Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene Stock Falls On Worries About Secondary Cancers
Celgene Stock Falls On Worries About Secondary Cancers
Celgene Stock Falls On Worries About Secondary Cancers
Submitted by
admin
on May 6, 2011 - 8:37am
Source:
Forbes
News Tags:
Celgene
cancer
Multiple Myeloma
Revlimid
Headline:
Celgene Stock Falls On Worries About Secondary Cancers
Do Not Allow Advertisers to Use My Personal information
